Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Recurrence × Brachytherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 40 Uterine Cervical Neoplasms 34 Breast Neoplasms 9 Vaginal Neoplasms 6 Neoplasms 6 Endometrial Neoplasms 6 Liver Neoplasms 5 Sarcoma 4 Vulvar Neoplasms 3 Uterine Neoplasms 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Hyperthermia 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Adenocarcinoma 3 Rhabdomyosarcoma 2 Retinoblastoma 2 Rectal Neoplasms 2 Radiation Injuries 2 Melanoma 2 Head and Neck Neoplasms 2 Gynecologic Cancer 2 Desmoplastic Small Round Cell Tumor 2 Deglutition Disorders 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Breast Carcinoma In Situ 2 Uveal Melanoma 1 Uterine Cervical Dysplasia 1

Interventions

Cyclophosphamide 102 Dexamethasone 57 Cytarabine 48 fludarabine phosphate 46 Rituximab 46 fludarabine 45 Gemcitabine 35 Lenalidomide 34 Etoposide 34 Peripheral Blood Stem Cell Transplantation 32 Radiotherapy 31 pembrolizumab 30 Filgrastim 29 Busulfan 29 Carboplatin 28 Methotrexate 26 Melphalan 26 Cyclosporine 26 Cisplatin 26 venetoclax 23 Paclitaxel 23 Mycophenolic Acid 23 Bortezomib 23 Whole-Body Irradiation 21 Granulocyte Colony-Stimulating Factor 20 Bevacizumab 20 Temozolomide 19 Antilymphocyte Serum 19 Oxaliplatin 18 Decitabine 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05715502 2025-04-30

FocaSaBra

The Greater Poland Cancer Centre

Phase NA Recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡